Introducing
Repair. Rejuvenate. Regrow. Naturally.
ExoGain is an advanced regenerative therapy that combines autologous exosomes with a rich concentration of growth factors to support natural tissue repair, cellular regeneration, and rejuvenation. Prepared from the patient's own blood, ExoGain provides a personalized and biocompatible solution for aesthetic and regenerative applications.
Redefining Regenerative Aesthetics
Developed using cutting-edge biotechnology, ExoGain harnesses your own body's healing intelligence to restore, rejuvenate, and regenerate — naturally.
Nanosized vesicles enriched with mRNA, proteins, and lipids that communicate regenerative signals between cells, activating stem cells and accelerating repair.
Platelets precisely activated to release high levels of PDGF, VEGF, EGF, and FGF — enhancing angiogenesis, collagen synthesis, and tissue regeneration.
ExoGain™ enables direct cell-to-cell signalling — something conventional PRP or GFC alone cannot achieve — resulting in deeper rejuvenation and faster results.
ELISA verified
ELISA analysis verifies ExoGain's elevated levels of PDGF, VEGF, EGF, and TGF-β, ensuring strong therapeutic activity. Consistent biomarker enrichment supports faster healing, improved outcomes, and better patient satisfaction.
Together, these bioactive nanocarriers and regenerative proteins deliver unmatched potency compared to conventional PRP or GFC therapies.
Clinical applications
Chairside preparation
Six steps, from venous draw to filtered autologous product.
Head to head
| Parameters | PRP | GFC | EXOS-GFC |
|---|---|---|---|
| Composition | Platelets with plasma | Platelet-derived growth factors | Autologous exosomes + growth factors |
| Mechanism | Indirect GF release | Direct GF delivery | Direct cellular communication + potent regenerative signaling |
| Regenerative capacity | Moderate | Improved | Superior — targets inflammation and stimulates true regeneration |
| Purity | Contains RBCs/WBCs | Contains cell debris | RBC-free, cell-free, highly purified exosomes |
| Onset of results | 4–6 weeks | 2–3 weeks | 1–2 weeks |
Nanoparticle Tracking Analysis (NTA)
Nanoparticle Tracking Analysis is a technique used to measure the size distribution and concentration of nanoparticles, including exosomes. NTA combines the principles of laser light scattering and Brownian motion to provide detailed insight into exosome populations.
2.05e+13 particles/ml
Original exosome concentration.
85.7% of particles between 30–150 nm, with a therapeutic peak at 100 nm.
>98% exosome and growth factor content with negligible impurities. NTA demonstrates excellent batch consistency, ensuring predictable regenerative outcomes.
What ships
Approved by the Central
Drugs Standard Control Organisation, India.
Get in touch
For clinicians, clinics and distribution partners. Tell us a little about your practice and we will send pricing, the full protocol and training details.
Kamal Encon Industries Limited
Plot No. 917, Sector-68, IMT Faridabad – 121001
Haryana, India
+91 99711 66553 ·
+91 80762 87050
info@kamalmedtech.com
Sweden office
Kamal Encon Psilox AB, Vallvägen 4A, S75651, Uppsala, Sweden
Exo